Categories AlphaGraphs, Earnings, Health Care
Eli Lilly (LLY) reports Q1 2020 earnings results
Adjusts EPS guidance amid COVID19 pandemic
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year.
Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in revenue increase of approx. $250 million for the quarter.
Net income was $1.457 billion or $1.60 per share, compared with net income of $4.242 billion or $4.31 per in the first quarter of 2019.
Josh Smiley, CFO commented on the outlook:
“Our revenue and operating margin outlook for 2020 is unchanged, but the economic and healthcare consequences of this pandemic are uncertain and could negatively affect our financial results later in 2020 and beyond, due to reduced non-COVID healthcare activities and global economic challenges. We are therefore widening the range of our 2020 EPS guidance to reflect both our underlying strong performance as well as future uncertainty; however, the long-term fundamentals of our business remain strong, as does our financial outlook for the mid-2020s and beyond.”
Past Performance
Most Popular
Coca-Cola (KO) Q1 2021 earnings release
The Coca-Cola Company (NYSE: KO) reported first-quarter 2021 financial results before the regular market hours on Monday. The beverage manufacturer reported fourth-quarter revenue of $9 billion, up 5% year-over-year. The
Earnings calendar for the week of April 19
The market rally gathered pace this week amid impressive quarterly results, led by the banking sector, and positive economic data. Leading stock indexes continued their winning streak, with S&P 500
Undeterred by crisis, Bank of America stays in expansion mode
Leading Wall Street banks recorded robust earnings in the early months of fiscal 2021 with the results benefiting from the release of credit loss reserves, in most cases. Taking advantage
